TipRanks
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market
ARQT
Arcutis Biotherapeutics
RESEARCH TOOLSreports
Want to see ARQT full AI Analyst Report?

Arcutis Biotherapeutics (ARQT) Ratios

989 Followers

Arcutis Biotherapeutics Ratios

ARQT's free cash flow for Q2 2026 was $0.92. For the 2026 fiscal year, ARQT's free cash flow was decreased by $ and operating cash flow was $0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.92 3.17 4.15 7.08 11.57
Quick Ratio
 2.67 2.99 3.97 6.80 11.37
Cash Ratio
 0.21 0.33 0.88 1.89 1.42
Solvency Ratio
 0.12 -0.04 -0.72 -1.03 -1.29
Operating Cash Flow Ratio
 0.25 -0.04 -1.38 -5.29 -6.82
Short-Term Operating Cash Flow Coverage
 5.66 -5.63 0.00 0.00 -392.26
Net Current Asset Value
$ 199.71M$ 167.74M$ 144.47M$ 77.73M$ 197.71M
Leverage Ratios
Debt-to-Assets Ratio
 0.23 0.01 0.32 0.60 0.45
Debt-to-Equity Ratio
 0.52 0.03 0.70 2.32 0.97
Debt-to-Capital Ratio
 0.34 0.03 0.41 0.70 0.49
Long-Term Debt-to-Capital Ratio
 0.32 0.03 0.40 0.69 0.49
Financial Leverage Ratio
 2.21 2.29 2.21 3.85 2.14
Debt Service Coverage Ratio
 2.08 0.10 -4.06 -7.76 -18.06
Interest Coverage Ratio
 2.47 -1.01 -4.73 -8.11 -19.27
Debt to Market Cap
 0.03 <0.01 0.06 0.90 0.24
Interest Debt Per Share
 0.98 0.14 1.14 3.40 3.96
Net Debt to EBITDA
 1.81 -14.77 -0.36 -0.52 -0.51
Profitability Margins
Gross Profit Margin
91.14%90.24%90.27%91.63%79.54%
EBIT Margin
8.88%-0.77%-57.10%-384.72%-8025.12%
EBITDA Margin
9.51%0.66%-55.78%-381.56%-7991.13%
Operating Profit Margin
7.38%-3.25%-65.33%-404.49%-8183.04%
Pretax Profit Margin
6.31%-3.98%-70.92%-434.57%-8449.76%
Net Profit Margin
6.15%-4.29%-71.25%-439.79%-8449.76%
Continuous Operations Profit Margin
6.15%-4.29%-71.25%-439.79%-8449.76%
Net Income Per EBT
97.34%107.82%100.46%101.20%100.00%
EBT Per EBIT
85.53%122.43%108.56%107.44%103.26%
Return on Assets (ROA)
5.84%-3.73%-40.14%-76.79%-69.32%
Return on Equity (ROE)
15.05%-8.52%-88.89%-295.65%-148.61%
Return on Capital Employed (ROCE)
10.44%-4.03%-47.93%-81.81%-73.31%
Return on Invested Capital (ROIC)
9.95%-4.02%-47.79%-81.61%-73.07%
Return on Tangible Assets
6.01%-3.86%-41.26%-78.27%-70.45%
Earnings Yield
0.84%-0.44%-8.31%-117.10%-38.24%
Efficiency Ratios
Receivables Turnover
 2.99 2.57 2.69 2.31 0.44
Payables Turnover
 6.22 2.93 1.35 0.42 0.09
Inventory Turnover
 1.06 1.62 1.32 0.38 0.10
Fixed Asset Turnover
 90.53 68.25 65.65 15.28 0.80
Asset Turnover
 0.95 0.87 0.56 0.17 <0.01
Working Capital Turnover Ratio
 1.59 1.40 0.73 0.17 <0.01
Cash Conversion Cycle
 408.72 242.45 141.53 241.61 201.94
Days of Sales Outstanding
 122.06 141.92 135.69 158.03 837.54
Days of Inventory Outstanding
 345.31 225.14 277.18 961.28 3.64K
Days of Payables Outstanding
 58.65 124.61 271.35 877.70 4.27K
Operating Cycle
 467.37 367.06 412.88 1.12K 4.47K
Cash Flow Ratios
Operating Cash Flow Per Share
 0.30 -0.04 -0.93 -3.56 -4.68
Free Cash Flow Per Share
 0.30 -0.05 -0.93 -3.57 -5.11
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 0.42
Free Cash Flow to Operating Cash Flow
 1.00 1.12 1.00 1.00 1.09
Dividend Paid and CapEx Coverage Ratio
 248.79 -8.20 -784.32 -577.24 -11.07
Capital Expenditure Coverage Ratio
 248.79 -8.20 -784.32 -577.24 -11.07
Operating Cash Flow Coverage Ratio
 0.34 -0.90 -1.01 -1.20 -1.27
Operating Cash Flow to Sales Ratio
 0.08 -0.01 -0.57 -4.14 -69.92
Free Cash Flow Yield
1.20%-0.17%-6.66%-110.56%-34.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 118.39 -223.38 -12.01 -0.85 -2.62
Price-to-Sales (P/S) Ratio
 7.05 9.82 8.57 3.76 220.96
Price-to-Book (P/B) Ratio
 15.47 19.50 10.70 2.52 3.89
Price-to-Free Cash Flow (P/FCF) Ratio
 83.51 -585.47 -15.00 -0.90 -2.90
Price-to-Operating Cash Flow Ratio
 86.80 -656.87 -15.02 -0.91 -3.16
Price-to-Earnings Growth (PEG) Ratio
 0.02 2.52 0.17 0.03 -0.07
Price-to-Fair Value
 15.47 19.50 10.70 2.52 3.89
Enterprise Value Multiple
 75.91 1.48K -15.73 -1.50 -3.27
Enterprise Value
 3.35B 3.66B 1.72B 341.37M 963.38M
EV to EBITDA
 75.91 1.48K -15.73 -1.50 -3.27
EV to Sales
 7.22 9.73 8.77 5.73 261.36
EV to Free Cash Flow
 85.56 -579.66 -15.35 -1.38 -3.43
EV to Operating Cash Flow
 85.21 -650.35 -15.37 -1.38 -3.74
Tangible Book Value Per Share
 1.59 1.37 1.22 1.19 3.68
Shareholders’ Equity Per Share
 1.69 1.49 1.30 1.28 3.81
Tax and Other Ratios
Effective Tax Rate
 0.03 -0.08 >-0.01 -0.01 0.00
Revenue Per Share
 3.55 2.96 1.62 0.86 0.07
Net Income Per Share
 0.22 -0.13 -1.16 -3.78 -5.66
Tax Burden
 0.97 1.08 1.00 1.01 1.00
Interest Burden
 0.71 5.19 1.24 1.13 1.05
Research & Development to Revenue
 0.20 0.20 0.39 1.86 49.49
SG&A to Revenue
 0.64 0.73 1.17 0.00 33.13
Stock-Based Compensation to Revenue
 0.09 0.11 0.21 0.65 8.87
Income Quality
 1.38 0.35 0.80 0.94 0.83
Currency in USD